Neurosity
Open Menu
Guide

Your Brain Runs on Light. Sort Of.

AJ Keller
By AJ Keller, CEO at Neurosity  •  February 2026
Photobiomodulation uses near-infrared light to stimulate cytochrome c oxidase in mitochondria, boosting ATP production in neurons. It's real biology, backed by real research, with real limitations.
Somewhere between sci-fi and settled science, there's a technology that shines invisible light through your skull and claims to make your brain work better. The mechanism is surprisingly well understood. The evidence is growing. And the honest picture of what PBM can and can't do is more interesting than the hype in either direction.
Explore the Crown
Non-invasive brain-computer interface with open SDKs

Someone Is Shining a Flashlight Into Their Brain Right Now. On Purpose.

Right this second, somewhere in the world, a person is sitting quietly with a device strapped to their head that is pumping invisible light through their skull and into their brain tissue. They paid good money for this. They do it several times a week. And there's a surprisingly solid biological reason why it might actually be doing something.

This is photobiomodulation. PBM for short. And if you've never heard of it, buckle up, because the story of how we figured out that specific wavelengths of light can directly affect brain cell metabolism is one of the stranger chapters in modern neuroscience.

It starts, as these things often do, with mitochondria. Yes, "the powerhouse of the cell." That phrase you memorized in eighth-grade biology and assumed you'd never need again? Turns out it's the key to understanding why someone would voluntarily beam near-infrared photons into their head.

Here's the 30-second version: your neurons need an absurd amount of energy to function. Mitochondria produce that energy. A specific enzyme in your mitochondria absorbs near-infrared light. When it does, it produces energy more efficiently. And near-infrared light can pass through your skull.

Connect those dots and you've got photobiomodulation.

But the 30-second version leaves out everything interesting. Like how this was discovered accidentally during laser experiments. Like the bizarre dose-response curve that means more light isn't better (and can actually be worse). Like the growing evidence that this might protect neurons from degenerative diseases. And like the critical limitation that PBM enthusiasts don't talk about enough: you can't actually tell whether it's working without a completely separate piece of technology.

Let's build the full picture.

The Optical Window: How Light Gets Through Your Skull

Before we get to what the light does inside the brain, we need to address the most obvious objection: how does light pass through bone?

Your skull is not transparent. If it were, things would be very weird. But "opaque to visible light" is not the same as "opaque to all light." Your skull, like most biological tissue, has what physicists call an optical window, a range of wavelengths where tissue absorption drops low enough that photons can actually make it through.

Visible light (the stuff you can see, roughly 400-700nm) gets absorbed or scattered almost immediately by melanin, hemoglobin, and water in your skin and skull. That's why your head isn't see-through. But as you move into the near-infrared range (roughly 700-1100nm), something shifts. Water absorbs less. Hemoglobin absorbs less. Melanin absorbs less. The tissue becomes partially transparent to these longer wavelengths.

At 810nm, which is the sweet spot for most brain PBM research, studies using cadaver tissue and computational modeling have shown that roughly 1 to 5% of applied light reaches the cortical surface. That might sound like almost nothing. But neurons are remarkably sensitive to photonic stimulation at the right wavelength. That 1-5% turns out to be enough.

Think about it this way. Your pupil lets in a tiny fraction of the light hitting your face, and that's enough to generate the entire visual world you experience. Biological systems don't need a firehose. They need the right signal at the right receptor.

Cytochrome C Oxidase: The Enzyme That Eats Light

So the near-infrared photons make it through the skull. They hit brain tissue. And then what?

This is where the biology gets genuinely beautiful.

Inside every neuron, inside every mitochondrion, there's an enzyme called cytochrome c oxidase (CCO). It's the fourth complex in the mitochondrial electron transport chain, the molecular assembly line that converts oxygen and nutrients into adenosine triphosphate (ATP), the energy currency of all life.

CCO has a remarkable property: it contains copper centers that absorb photons in the near-infrared range, with peak absorption around 810nm. This isn't a coincidence exploited by modern science. It's an ancient molecular feature. CCO evolved to use light-absorbing metal centers for its electron transport function, and it just so happens that those centers respond to external near-infrared illumination.

Here's what happens when near-infrared photons hit CCO:

Step 1: Nitric oxide displacement. Under normal conditions, nitric oxide (NO) can bind to CCO and inhibit its function, essentially putting a brake on ATP production. Near-infrared light knocks that nitric oxide loose. The brake comes off. The electron transport chain runs more freely.

Step 2: Increased electron transport. With the inhibition removed, electrons flow through the transport chain more efficiently. More electrons flowing means more protons get pumped across the mitochondrial membrane. More protons means a bigger electrochemical gradient. And a bigger gradient means the ATP synthase enzyme spins faster, churning out more ATP.

Step 3: Controlled ROS signaling. The light also triggers a brief, mild increase in reactive oxygen species (ROS). In large amounts, ROS are destructive. But in small, controlled bursts, they act as signaling molecules that activate transcription factors like NF-kB and AP-1. These factors turn on genes involved in cell survival, anti-inflammatory responses, and neuroprotection.

The net result: more cellular energy, reduced inflammation, and activation of protective pathways. All from photons passing through an enzyme.

Why 810nm Specifically?

Different wavelengths target different chromophores (light-absorbing molecules) in tissue. The 810nm wavelength hits the sweet spot for cytochrome c oxidase absorption while also falling within the optical window for tissue penetration. Shorter wavelengths like 630-670nm (visible red) also affect CCO but penetrate tissue far less effectively, making them better suited for surface applications like skin treatments. For transcranial applications where light needs to pass through scalp, skull, and meninges to reach cortical tissue, 810nm is the wavelength with the best combination of absorption and penetration.

Your Brain Is an Energy Hog (And That's the Whole Point)

To understand why boosting mitochondrial ATP production in the brain matters, you need to appreciate just how energy-hungry your brain is.

Your brain accounts for about 2% of your body weight. It consumes roughly 20% of your body's total energy. Pound for pound, it's the most metabolically expensive organ you have.

And neurons aren't just casually sipping energy. They're guzzling it. Every time a neuron fires an action potential, ions flood across its membrane. Restoring the resting potential requires ATP-powered ion pumps. Synthesizing neurotransmitters requires ATP. Packaging neurotransmitters into vesicles requires ATP. Releasing them, recycling them, maintaining the structural integrity of synapses. All ATP.

A single cortical neuron can consume roughly 4.7 billion ATP molecules per second during active signaling. Multiply that across the tens of billions of neurons firing at any given moment and you start to understand why the brain commandeers so much of the body's energy supply.

Here's the thing that makes this relevant to photobiomodulation: when energy supply drops, brain function degrades. Not dramatically, not all at once, but measurably. Reaction times slow. Attention wavers. Memory consolidation gets less efficient. The brain starts triaging, directing limited resources to essential functions at the expense of higher-order cognitive processes.

This is what happens with aging (mitochondrial efficiency declines about 8% per decade after age 30). It's part of what happens with neurodegenerative diseases (Alzheimer's brains show dramatically reduced mitochondrial function years before symptoms appear). And it's the basis of the argument for transcranial PBM: if you can boost ATP production in neurons, even modestly, you might support cognitive function in ways that accumulate over time.

Transcranial PBM: Devices, Protocols, and the Dose Problem

The theory is elegant. But translating "near-infrared light boosts mitochondrial function" into "put this device on your head for 20 minutes" involves some genuinely thorny engineering challenges.

The Devices

The most extensively studied consumer brain PBM device is the Vielight Neuro Gamma. It delivers 810nm near-infrared light through LEDs positioned on the scalp over the default mode network nodes (frontal and parietal regions), plus an intranasal diode that sends light up through the thin bone of the nasal cavity to reach the ventral prefrontal cortex from below.

The Vielight Neuro Gamma pulses its light at 40 Hz, matching the gamma brainwave frequency. The idea is that pulsed delivery at a biologically relevant frequency might entrain neural oscillations while simultaneously boosting mitochondrial function. The Vielight Neuro Alpha uses the same hardware but pulses at 10 Hz (alpha frequency). Each device costs around $1,800.

Other devices on the market range from full LED helmets to handheld wands, with prices from $200 to $3,000+. Quality, power density, and research backing vary enormously.

Device/TypeWavelengthPulse FrequencyDelivery MethodApproximate Cost
Vielight Neuro Gamma810nm40 HzTranscranial LEDs + intranasal$1,800
Vielight Neuro Alpha810nm10 HzTranscranial LEDs + intranasal$1,800
LED Helmet Devices630-850nm (varies)Continuous or pulsed (varies)Transcranial LEDs$200-$1,500
Handheld NIR Units810-850nmVariesTargeted transcranial$100-$500
Clinical/Research PBM808-810nmProtocol-dependentHigh-power laser or LED arrays$3,000-$10,000+
Device/Type
Vielight Neuro Gamma
Wavelength
810nm
Pulse Frequency
40 Hz
Delivery Method
Transcranial LEDs + intranasal
Approximate Cost
$1,800
Device/Type
Vielight Neuro Alpha
Wavelength
810nm
Pulse Frequency
10 Hz
Delivery Method
Transcranial LEDs + intranasal
Approximate Cost
$1,800
Device/Type
LED Helmet Devices
Wavelength
630-850nm (varies)
Pulse Frequency
Continuous or pulsed (varies)
Delivery Method
Transcranial LEDs
Approximate Cost
$200-$1,500
Device/Type
Handheld NIR Units
Wavelength
810-850nm
Pulse Frequency
Varies
Delivery Method
Targeted transcranial
Approximate Cost
$100-$500
Device/Type
Clinical/Research PBM
Wavelength
808-810nm
Pulse Frequency
Protocol-dependent
Delivery Method
High-power laser or LED arrays
Approximate Cost
$3,000-$10,000+

The Dose Problem

And here's where things get really complicated.

PBM follows what's called a biphasic dose response, sometimes called the Arndt-Schulz curve. It looks like an inverted U. Too little light and nothing measurable happens. The right amount and you get the beneficial effects: more ATP, reduced inflammation, neuroprotective signaling. Too much light and the response reverses. Excessive photon energy generates too many reactive oxygen species, overwhelming the cell's antioxidant defenses and actually impairing function.

The therapeutic window depends on:

  • Wavelength (810nm is the most studied for brain applications)
  • Power density (measured in milliwatts per square centimeter at the tissue surface)
  • Energy density (measured in joules per square centimeter, combining power and time)
  • Pulse frequency (continuous vs. pulsed, and at what frequency)
  • Treatment duration (typically 10-25 minutes per session)
  • Skull thickness (which varies significantly between individuals and even between locations on the same skull)

That last variable is a real problem. A device calibrated to deliver the right dose to the cortex of a person with thin skull bones might be underdosing someone with thicker bones, or vice versa. There's no consumer device on the market that measures skull thickness and adjusts accordingly.

This is why PBM research is littered with inconsistent results. A study that finds a positive effect at one set of parameters might not replicate at a different lab using slightly different equipment. It's not that PBM doesn't work. It's that the dose-response relationship is finicky enough that small parameter differences can flip the outcome.

What the Research Actually Shows

Let's walk through the evidence honestly, separating what's well-supported from what's still speculative.

Healthy Cognition

The most cited work comes from Francisco Gonzalez-Lima's lab at the University of Texas at Austin. In a series of studies, his group showed that a single session of transcranial PBM (using 1064nm laser, not 810nm LED) improved reaction time on a sustained attention task and improved working memory in healthy young adults. Follow-up imaging confirmed that PBM increased CCO activity in the prefrontal cortex.

A 2022 study published in Aging and Disease found that multi-session PBM improved executive function, attention, and processing speed in healthy older adults. The improvements were modest but statistically significant, and they persisted for at least two weeks after the final session.

Neuroprotection and Neurodegeneration

This is where the PBM story gets genuinely exciting. And it's the "I had no idea" moment for most people who encounter this research.

In 2017, a small pilot study by Saltmarche and colleagues used the Vielight Neuro device on five patients with mild-to-moderate Alzheimer's disease. After 12 weeks of treatment, all five showed improvements on the Mini-Mental State Examination (MMSE) and the Alzheimer's Disease Assessment Scale. The improvements reversed when treatment stopped.

That was a tiny, uncontrolled pilot. But it built on something stronger: a decade of animal research showing that near-infrared light reduces amyloid-beta plaques, decreases neuroinflammation, and improves cognitive function in mouse models of Alzheimer's. The mechanism makes biological sense. Alzheimer's brains show severely compromised mitochondrial function. If PBM can partially restore that function, it could slow the cascade of damage.

A larger randomized controlled trial, the "BEACON" study, was completed in 2023 with 228 participants. The results were mixed: improvements on some cognitive measures but not all, and the effect sizes were smaller than the pilot data had suggested. This is the pattern of honest science. Exciting early results moderated by larger, more rigorous trials.

PBM and Traumatic Brain Injury: The Most Compelling Case

The strongest clinical evidence for transcranial PBM may be in traumatic brain injury (TBI). Multiple case studies and small trials have shown improvements in cognition, mood, and sleep quality in TBI patients treated with near-infrared light. The proposed mechanism: TBI disrupts mitochondrial function in the injured tissue, and PBM helps restore it. A 2014 case series by Naeser and colleagues at Boston University found that chronic TBI patients who received transcranial LED treatments showed improvements in attention, inhibition, and executive function that persisted at a two-month follow-up. The NALS (Neuro-Amelioration of Light Sources) study has since expanded this work with larger sample sizes. TBI remains the PBM brain application closest to clinical validation.

Mood and Mental Health

Several studies have explored PBM for depression, with intriguing results. A 2019 randomized controlled trial by Cassano and colleagues at Massachusetts General Hospital found that transcranial PBM significantly reduced depression and anxiety scores compared to sham treatment. The proposed mechanism: prefrontal cortex hypoactivity is a hallmark of depression, and PBM may boost metabolic activity in these underperforming regions.

The Honest Summary

The evidence for transcranial PBM falls into a frustrating middle ground. The biology is solid. The mechanism makes sense. The animal data is compelling. The human data is promising but hampered by small sample sizes, inconsistent protocols, and the fiendish dose-response problem. It's not snake oil. But it's not proven medicine either. It lives in that uncomfortable space where the science is real but the certainty isn't there yet.

The Blind Spot: You Can't See What You Can't Measure

Here's the part of the PBM story that doesn't get enough attention.

When you sit down with a PBM device on your head, photons enter your skull. That much is physics. But then what? Did your mitochondria actually respond? Did ATP production increase? Did your prefrontal cortex become more metabolically active? Did any of that translate into meaningful changes in neural function?

The PBM device can't tell you. It has no sensors. It delivers light and hopes for the best.

This is fundamentally different from technologies that measure what they're affecting. And it's one of the most important things to understand about PBM's place in the brain technology landscape.

Neurosity Crown
The Neurosity Crown gives you real-time access to your own brainwave data across 8 EEG channels at 256Hz, with on-device processing and open SDKs.
See the Crown

If you really want to know whether PBM is affecting your brain, you need EEG. Electroencephalography measures the electrical activity of neural populations in real time. After a PBM session, EEG can detect changes in brainwave power spectra, shifts in alpha or beta activity, changes in inter-regional coherence, and alterations in event-related potentials during cognitive tasks.

Several research groups have done exactly this. A 2021 study by Wang and colleagues used EEG to measure brain activity before and after transcranial PBM and found increased alpha power and improved alpha peak frequency, both associated with better cognitive function. Without the EEG data, those changes would have been invisible.

This points to something important about how PBM and EEG relate to each other. PBM is a stimulation technology. It sends energy into the brain. EEG is a measurement technology. It reads what the brain is doing. They're complementary in the most literal sense: one acts, the other observes.

If you're going to invest in brain technology, this distinction matters more than most people realize. A stimulation device without measurement is like driving with the dashboard turned off. You might be going somewhere. You have no way to check.

PBM vs Other Brain Stimulation Technologies: Which Is Better?

Photobiomodulation isn't the only way to stimulate the brain from outside the skull. Putting it in context with other approaches helps clarify what makes it unique and where it falls short.

TechnologyMechanismInvasivenessFDA Status (Brain)Measurement Built In?
Photobiomodulation (PBM)Near-infrared light boosts mitochondrial ATPNon-invasiveNot approvedNo
Transcranial Direct Current Stimulation (tDCS)Weak electrical current modulates neuronal excitabilityNon-invasiveNot approved for cognitionNo
Transcranial Magnetic Stimulation (TMS)Magnetic pulses induce electrical currents in cortexNon-invasiveApproved for depression (rTMS)No
Neurofeedback (via EEG)Real-time brain data enables operant conditioningNon-invasiveEEG devices regulated as wellnessYes, inherently
Deep Brain Stimulation (DBS)Implanted electrodes deliver electrical pulsesInvasive (surgery required)Approved for Parkinson's, epilepsySome newer models
Technology
Photobiomodulation (PBM)
Mechanism
Near-infrared light boosts mitochondrial ATP
Invasiveness
Non-invasive
FDA Status (Brain)
Not approved
Measurement Built In?
No
Mechanism
Weak electrical current modulates neuronal excitability
Invasiveness
Non-invasive
FDA Status (Brain)
Not approved for cognition
Measurement Built In?
No
Technology
Transcranial Magnetic Stimulation (TMS)
Mechanism
Magnetic pulses induce electrical currents in cortex
Invasiveness
Non-invasive
FDA Status (Brain)
Approved for depression (rTMS)
Measurement Built In?
No
Technology
Neurofeedback (via EEG)
Mechanism
Real-time brain data enables operant conditioning
Invasiveness
Non-invasive
FDA Status (Brain)
EEG devices regulated as wellness
Measurement Built In?
Yes, inherently
Technology
Deep Brain Stimulation (DBS)
Mechanism
Implanted electrodes deliver electrical pulses
Invasiveness
Invasive (surgery required)
FDA Status (Brain)
Approved for Parkinson's, epilepsy
Measurement Built In?
Some newer models

The pattern is revealing. Every stimulation-only technology shares the same blind spot: they push energy into the brain without measuring the response. PBM pushes photons. tDCS pushes current. TMS pushes magnetic pulses. None of them can tell you what happened as a result.

EEG-based neurofeedback is the exception. It's both the intervention and the measurement. The brain data is the training signal. Every session generates evidence of what your brain actually did.

This is why serious PBM researchers almost always include EEG as an outcome measure. And it's why anyone using PBM at home would benefit from pairing it with real-time brain monitoring. Not because PBM doesn't work. But because you deserve to know whether it's working for you.

The Combination Approach: Passive Stimulation Meets Active Measurement

There's a growing community of neuroscience enthusiasts and biohackers who don't see PBM and EEG as competing technologies. They see them as two halves of a complete system.

The logic is straightforward. PBM delivers energy to your neurons, potentially enhancing mitochondrial function and priming neural circuits for better performance. EEG measures what your neurons are actually doing, both before and after the stimulation. Together, you get intervention plus verification.

A practical protocol might look like this: take a 5-minute EEG baseline to capture your pre-session brainwave state. Run a 20-minute PBM session. Take another EEG reading immediately after. Compare the two. Did alpha power increase? Did your focus scores shift? Did the power spectrum change in ways consistent with enhanced cortical metabolism?

This kind of N-of-1 experimentation, tracking your own brain's response to an intervention over repeated sessions, is exactly what consumer EEG devices like the Neurosity Crown were designed for. The Crown's 8 channels cover frontal, central, parietal, and occipital regions, giving you enough spatial coverage to detect broad changes in cortical activity. Its 256Hz sampling rate captures the full range of brainwave frequencies through gamma. And its SDK lets developers build custom analysis tools that go far beyond what any off-the-shelf app provides.

You don't have to take anyone's word for whether PBM is affecting your brain. You can see the data for yourself.

What PBM Can't Do (And Why That Matters)

Let's be clear-eyed about the limitations, because honesty about what a technology can't do is what makes claims about what it can do trustworthy.

PBM can't teach your brain new patterns. It delivers energy. It doesn't reorganize neural circuits. Extra ATP doesn't teach your prefrontal cortex to sustain attention or your default mode network to quiet down during focused work. For that, you need active training, the kind that neurofeedback provides through real-time feedback and operant conditioning.

PBM can't personalize itself to your brain. The device delivers the same wavelength, power, and pulse frequency to everyone. Your brain's specific needs, its particular pattern of strengths and weaknesses, don't factor in. EEG-based approaches, by contrast, respond to your individual brain activity in real time.

PBM effects appear to be transient. Most studies show benefits that fade within hours to days without continued sessions. This is consistent with the energy-boost mechanism: once you stop delivering extra photons, mitochondrial function returns to baseline. Contrast this with neurofeedback, where trained changes in brainwave patterns persist for months after training ends because they're based on learned neural reorganization, not temporary energy supplementation.

PBM has no built-in feedback loop. You can't tell, from the device, whether anything changed. This makes it difficult to optimize your protocol, track your progress, or distinguish real effects from placebo.

None of these limitations make PBM worthless. They make it incomplete. Like a nutritional supplement that might help your body perform better, but can't replace training and can't tell you whether it's actually working.

The "I Had No Idea" Moment: Why Your Brain Might Already Be Doing PBM to Itself

Here's something that will rearrange how you think about this entire topic.

In 2016, researchers at the University of Alberta published a study in PLOS ONE showing that neurons produce their own biophotons, ultra-weak light emissions generated as a byproduct of oxidative metabolism in mitochondria. These aren't metaphorical "sparks." They're actual photons, in the visible and near-infrared spectrum, emitted by your brain cells during normal function.

The emissions are incredibly faint, roughly 10 to 1,000 photons per second per square centimeter of cortical tissue. You'll never see them with your eyes. But they're real, and they've been detected using ultra-sensitive photomultiplier tubes.

Here's where it gets wild: a 2020 follow-up study proposed that these biophotons might not just be metabolic waste. They might serve as a signaling mechanism. The hypothesis, still speculative but supported by computational models, is that neurons could use biophotonic communication as a supplementary channel alongside their well-known electrical and chemical signaling systems. Light, traveling through the partially translucent neural tissue, could carry information between cells that aren't directly connected by synapses.

If this hypothesis holds up (and that's a big "if"), it would mean your brain is already using light as part of its information-processing architecture. Photobiomodulation, in this framing, wouldn't be introducing something foreign. It would be amplifying a communication system the brain already uses.

We're a long way from confirming this. But the fact that neurons emit and potentially respond to their own near-infrared light adds a layer of biological plausibility to PBM that most people, even many PBM advocates, don't know about.

Where PBM Fits in the Brain Technology Landscape

PBM is a stimulation technology. It's passive, unidirectional, and operates without any feedback from the brain it's stimulating. It may boost the raw energy available to your neurons. The evidence suggests it's safe at standard parameters, biologically plausible, and potentially beneficial for specific conditions like TBI and age-related cognitive decline.

But it's not a complete brain optimization strategy. And it's certainly not a replacement for measurement.

The brain is not simply an organ that needs more fuel. It's a system of breathtaking complexity, 86 billion neurons forming trillions of connections, generating electrical patterns that change millisecond by millisecond. Understanding that system, tracking its states, and learning to influence those states requires more than photons. It requires data.

This is why EEG and PBM are natural partners, not competitors. PBM provides a potential input (energy). EEG provides the output (brain state data). Together, they create a feedback loop that neither can achieve alone. Stimulate, then measure. Adjust, then stimulate again. Track changes over weeks and months. Let the data guide the process.

The Neurosity Crown sits squarely on the measurement side of this equation. Its 8 EEG channels capture the electrical signatures of your cortical activity in real time. Its on-device N3 chipset processes that data without sending your brain information to the cloud. Its JavaScript and Python SDKs let you build custom tools that track whatever metrics matter to your protocol. And its integration with AI tools through the Model Context Protocol (MCP) opens up possibilities for intelligent analysis of your brain data that would have been science fiction five years ago.

Whether you're exploring PBM, neurofeedback, meditation, or any other approach to cognitive enhancement, the question remains the same: is it actually doing anything to your brain?

EEG is how you answer that question.

Your Brain Deserves More Than Faith-Based Optimization

We live in a remarkable moment for brain technology. For the first time, consumers have access to tools that can both stimulate and measure the brain outside of a clinical setting. The stimulation side, PBM included, is full of promising but unproven approaches that might help and probably won't hurt. The measurement side gives you something far more valuable than a maybe. It gives you evidence.

Photobiomodulation is worth watching. The mechanism is real. The research is growing. The applications in neuroprotection and TBI recovery are genuinely exciting. If you try it, pair it with measurement. Know what it's doing to your specific brain. Don't just shine a light and hope.

Because the most interesting thing about your brain isn't how much energy it uses. It's the patterns that energy creates. The oscillations that rise and fall as you think, focus, drift, and dream. The electrical signatures of a mind at work.

PBM might give your neurons a little extra fuel. But seeing those patterns in real time, understanding them, learning to shape them? That's not a supplement. That's self-knowledge. And self-knowledge, as it turns out, is the one cognitive enhancer that never wears off.

Stay in the loop with Neurosity, neuroscience and BCI
Get more articles like this one, plus updates on neurotechnology, delivered to your inbox.
Frequently Asked Questions
What is photobiomodulation?
Photobiomodulation (PBM) is the use of specific wavelengths of light, typically near-infrared in the 600-1100nm range, to stimulate biological tissue. When applied to the brain (transcranial PBM), near-infrared photons pass through the skull and are absorbed by cytochrome c oxidase in neuronal mitochondria, boosting ATP production and cellular energy metabolism.
How does near-infrared light reach the brain through the skull?
Near-infrared light in the 800-850nm range penetrates biological tissue more effectively than visible light because it falls within the 'optical window' where absorption by water, hemoglobin, and melanin is minimized. Studies using cadaver tissue and computational modeling show that roughly 1-5% of applied near-infrared light at 810nm reaches the cortical surface through the scalp and skull, which is enough to trigger measurable biological effects in mitochondria.
What is the difference between photobiomodulation and red light therapy?
Red light therapy is a broad commercial term that covers any therapeutic use of red or near-infrared light, including skin treatments, wound healing, and pain management. Photobiomodulation is the scientific term for the underlying biological mechanism. Transcranial photobiomodulation specifically refers to PBM directed at the brain through the skull. Not all red light therapy devices deliver the wavelengths, power densities, or treatment durations needed for meaningful transcranial effects.
Is photobiomodulation FDA approved for brain use?
No. As of 2026, no photobiomodulation device has FDA approval for cognitive enhancement, neuroprotection, or any brain-related indication. The FDA has cleared some PBM devices for pain management and wound healing. Consumer brain PBM devices are typically marketed as wellness products or sold for research use only.
Can you measure the effects of photobiomodulation on the brain?
Yes, but not with the PBM device itself. You need a separate brain measurement tool like EEG to verify whether PBM changed your brain activity. EEG can detect shifts in brainwave power, particularly increases in alpha and beta activity, that some studies have reported after PBM sessions. This is one reason researchers recommend pairing PBM with EEG monitoring.
What devices are used for transcranial photobiomodulation?
The most researched consumer device is the Vielight Neuro series, which delivers 810nm near-infrared light through transcranial LEDs and an intranasal diode. The Vielight Neuro Gamma pulses at 40Hz and costs around $1,800. Other options include various LED helmet devices and handheld near-infrared units, though quality and research backing vary significantly across manufacturers.
Copyright © 2026 Neurosity, Inc. All rights reserved.